| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 08/31/2011 | EP1481671B1 Compositions and foods for improving lipid metabolism |
| 08/31/2011 | EP1079824B1 Triterpene compositions and methods for use thereof |
| 08/31/2011 | CN1918119B Bicycloester derivative |
| 08/31/2011 | CN1914194B Therapeutic agent for vasospasm accompanying bypass operation |
| 08/31/2011 | CN1659162B Tricyclic thrombin receptor antagonists |
| 08/31/2011 | CN102171221A Novel fused aminodihydrothiazine derivative |
| 08/31/2011 | CN102171220A Pyrazolo [5, 1-b] oxazole derivatives as CRF1 antagonists |
| 08/31/2011 | CN102171210A Imidazopyridin-2-on derivative |
| 08/31/2011 | CN102171204A 8-substituted isoquinoline derivative and use thereof |
| 08/31/2011 | CN102171192A Indazole compound |
| 08/31/2011 | CN102171191A Indazole derivative |
| 08/31/2011 | CN102170876A Physical endurance improving agent, anti-fatigue agent or fatigue recovering agent comprising amino acid composition as active ingredient |
| 08/31/2011 | CN102166320A Traditional Chinese medicine preparation for eliminating toxins and relieving stagnation of people with toxic stagnation physique and preparation method and application thereof |
| 08/31/2011 | CN102166315A Traditional Chinese medicine preparation for people with damp heat constitution to remove and resolve humidity, preparation method thereof and application thereof |
| 08/31/2011 | CN102166253A Oil-in-water type elsholtzia oil nano emulsion preparation and method for preparing same |
| 08/31/2011 | CN102166224A Antibiotic mate for treating colibacillosis and preparation method thereof |
| 08/31/2011 | CN102166212A Method for making benidipine hydrochloride quickly dissolved from tablets |
| 08/31/2011 | CN102166207A Application of artemether in preparation of anopheline mosquito immune system inhibitor |
| 08/31/2011 | CN101829079B Application of compound of (E)-5-[6-hydroxy-5-(3-methyl-1-butenyl)-2-benzofuranyl] phenyl-1, 3-diol to preparation of pancrelipase inhibitor |
| 08/31/2011 | CN101612159B Application of 20(S)-ginsenoside Rh2 compound in preparing anti-fatigue medicament |
| 08/31/2011 | CN101481395B Preparation of lactitol |
| 08/31/2011 | CN101395134B 17 beta hsd type 5 inhibitor |
| 08/31/2011 | CN101384550B Amide derivative or salt thereof |
| 08/31/2011 | CN101204202B Ruminant granular humic acid feed |
| 08/31/2011 | CN101200469B Separation of regioisomers of metal phthalocyanines |
| 08/30/2011 | US8008501 Inhibit the Immunoglobulin E (IgE) receptor signaling cascade; associated with mast and/or basophil cell degranulation such as allergic diseases, scarring, inflammation; e.g. 5-Methyl-3-phenyl-4-isoxazolecarboxylic acid, 2-methyl-4-quinolinyl Ester |
| 08/30/2011 | US8008353 Alzheimer's disease; small molecule amine salts |
| 08/30/2011 | US8008333 Inducing ovulation; increasing response to follicle stimulating hormone |
| 08/30/2011 | US8008330 Combinations comprising epothilones and pharmaceutical uses thereof |
| 08/30/2011 | US8008321 Imidazo[1,5-a]pyridin-3-yl)(3-methoxy-4-nitrophenyl)methanone; a and b fibroblast growth factor receptors (FGFR) antagonist; anticarcinogenic, antitumor: lung, breast, prostate, melanomas, gliomas; antiinflammatory, vascular smooth muscle cells: atherosclerosis, restenosis, stent and bypass complications |
| 08/30/2011 | US8008308 Phosphonate compounds |
| 08/30/2011 | US8008282 Lipoxin analogs as novel inhibitors of angiogenesis |
| 08/30/2011 | US8008266 Nucleic acids containing unmethylated cytosine-guanine dinucleotides activate lymphocytes and redirect an immune response from th2 to th1 |
| 08/30/2011 | US8008027 Methods of screening for compounds that modulate the activity of ADEC, a chemokine expressed in inflamed adenoid |
| 08/30/2011 | US8007830 Oral granules of montelukast sodium; e.g. spray-dried mannitol coated with said drug; may be ingested directly or mixed with food or other comestibles for patients who have difficulty swallowing |
| 08/30/2011 | US8007799 Vascular endothelial cell growth factor antagonists and uses thereof |
| 08/30/2011 | CA2493883C Drugs for improving the prognosis of brain injury and a method of screening the same |
| 08/30/2011 | CA2492021C Use of ginkgo biloba extracts in order to promote muscle mass to the detriment of fatty mass |
| 08/30/2011 | CA2479665C Nanoparticulate compositions of angiogenesis inhibitors |
| 08/30/2011 | CA2460911C 2-propynyl adenosine analogs having a2a agonist activity and compositions thereof |
| 08/30/2011 | CA2459757C Combination |
| 08/30/2011 | CA2440473C Metalloproteinase inhibitors |
| 08/30/2011 | CA2406392C Substituted benzoic acid amides and use thereof for the inhibition of angiogenesis |
| 08/30/2011 | CA2393352C Adamantane derivatives |
| 08/30/2011 | CA2378893C In vivo induction for enhanced function of isolated hepatocytes |
| 08/30/2011 | CA2283630C Ligand/lytic peptide compositions and methods of use |
| 08/30/2011 | CA2251647C Substituted isoquinoline-3-carboxamides, their preparation and their use as pharmaceuticals |
| 08/25/2011 | WO2011102529A1 Epithelial cell-cell adhesion enhancer, and ameliorating, therapeutic or prophylactic agent for allergic diseases using same |
| 08/25/2011 | WO2011102514A1 Aromatic ring compound |
| 08/25/2011 | WO2011102436A1 Tgf-β signal transduction inhibitor |
| 08/25/2011 | WO2011102404A1 Imidazole derivative |
| 08/25/2011 | WO2011102399A1 Heterocyclic compound |
| 08/25/2011 | WO2011102149A1 Use of ep4 receptor antagonists in the treatment of il-23 mediated diseases |
| 08/25/2011 | WO2011100983A1 Casein, a novel curcumin drug carrier system |
| 08/25/2011 | US20110207834 Highly purified polylactic acid or a derivative thereof, a salt of the same, and purification method thereof |
| 08/25/2011 | US20110207819 Fat Emulsion for Artificially Feeding Seriously Ill Intensive Care Patients |
| 08/25/2011 | US20110207801 Novel Genes, Compositions, and Methods for Modulating the Unfolded Protein Response |
| 08/25/2011 | US20110207763 8-carboxamido-2,6-methano-3-benzazocines |
| 08/25/2011 | US20110207721 Purine derivatives as kinase inhibitors |
| 08/25/2011 | US20110207693 Oral B12 Therapy |
| 08/25/2011 | US20110207664 Materials and Methods Involving Hybrid Vascular Endothelial Growth Factor DNAs and Proteins |
| 08/25/2011 | US20110206755 Methods and products for manipulating uncoupling protein expression |
| 08/25/2011 | US20110206675 Anti-notch3 agonist antibodies and their use in the treatment of notch3-related diseases |
| 08/25/2011 | US20110206617 Modified polysaccharides for drug and contrast agent delivery |
| 08/25/2011 | US20110206613 METHOD AND APPLICATION OF UNSYMMETRICALLY meso-SUBSTITUTED PORPHYRINS AND CHLORINS FOR PDT |
| 08/25/2011 | US20110206612 Novel screens to identify agents that modulate retinal blood vessel function and pericyte function and diagnostic and therapeutic application therefor |
| 08/25/2011 | US20110206610 Compositions and methods for enhancing drug delivery across and into epithelial tissues |
| 08/25/2011 | US20110206607 Imidazol (1,2-a)pyridines and related compounds with activity at cannabinoid cb2 receptors |
| 08/25/2011 | US20110206604 Nitroimidazole-amino acid hypoxia contrast medium, preparation method and use thereof |
| 08/25/2011 | CA2790783A1 Epithelial cell-cell adhesion enhancer, and ameliorating, therapeutic or prophylactic agent for allergic diseases using same |
| 08/25/2011 | CA2790284A1 Heterocyclic compound |
| 08/25/2011 | CA2789665A1 Use of ep4 receptor antagonists in the treatment of il-23 mediated diseases |
| 08/24/2011 | EP2360253A1 RNA sequence-specific mediators of RNA interference |
| 08/24/2011 | EP2360252A1 Immunostimulatory nucleic acid molecules comprising GTCGTT motifs |
| 08/24/2011 | EP2360169A2 PSMA antibodies |
| 08/24/2011 | EP2360166A1 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase |
| 08/24/2011 | EP2360155A1 2-aminopyridin-4-one and 2-aminopyridine derivative both having bace1-inhibiting activity |
| 08/24/2011 | EP2359835A1 Viral infection therapeutic drug containing polyalkyleneimine |
| 08/24/2011 | EP2359819A1 Substituted styryl benzylsulfones for treating proliferative disorders |
| 08/24/2011 | EP2359688A1 Organ arrest, protection and preservation |
| 08/24/2011 | EP2358721A1 Modulators of cystic fibrosis transmembrane conductance regulator |
| 08/24/2011 | EP2358391A1 Use of an immunoglobulin g (igg) concentrate depleted of anti-a and anti-b antibodies for treating neonatal jaundice caused by maternal-foetal incompatibility with respect to the abo system |
| 08/24/2011 | EP2358365A1 Glycogen synthase kinase-3 beta inhibitors containing 7-hydroxy-benzoimidazole-4-yl-methanone derivatives |
| 08/24/2011 | EP1867332B1 Pharmaceutical composition and method using antifungal agent in combination |
| 08/24/2011 | EP1506774B1 Smooth muscle peristole inhibitor |
| 08/24/2011 | EP1499729B1 Derivatives of the nf-kappab inducing enzyme, their preparation and use |
| 08/24/2011 | EP1490338B1 Use of an alfa2-adrenoreceptor antagonist for cns-related diseases |
| 08/24/2011 | EP1485353B1 New inhibitors of histone deacetylase |
| 08/24/2011 | EP1480962B1 5-phenylthiazole derivatives and use as pi3 kinase inhibitors |
| 08/24/2011 | EP1333833B1 Novel trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compound for the treatment of CSBP/p38 kinase mediated diseases |
| 08/24/2011 | EP1259544B1 Heterologous polypeptide of the tnf family |
| 08/24/2011 | EP1023067B2 The use of inhibitors of the renin-angiotensin system for the treatment of hypoxia or impaired metabolic function |
| 08/24/2011 | EP0981618B2 Anti-apo-2 antibody |
| 08/24/2011 | CN102164902A 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase |
| 08/24/2011 | CN102164596A Prophylactic/ameliorating agent for adult diseases comprising 5-aminolevulinic acid, derivative of 5-aminolevulinic acid, or salt of 5-aminolevulinic acid or the derivative of 5-aminolevulinic acid as active ingredient |
| 08/24/2011 | CN102164591A Combinations of a rate control agent and an A-2-alpha receptor antagonist for use in multidetector computed tomography methods |
| 08/24/2011 | CN102161991A Single-strand multi-target interfering nucleic acid molecule and application thereof |
| 08/24/2011 | CN102160882A Donkey-hide glue and angelica root oral liquid capable of dredging micro-circulation and improving healthy condition |
| 08/24/2011 | CN101869661B Chinese medicinal oral liquid for treating vocal nodule |
| 08/24/2011 | CN101836975B Application of isopentene group flavonoid compound used as pancreatic lipase inhibitor |